Earnings History Data for Cytosorbents Corporation (CTSO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Cytosorbents Corporation
CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 04-11-2021 | AH | 4:15 PM ET (Nov 4) |
CTSO | Cytosorbents Corporation | 252.47 | -0.15 | -0.11 | -0.02 | Cytosorbents EPS misses by $0.03, beats on revenue [11/4/2021 4:29 PM] |
6.25 | 0.14 (2.29%) |
6.25 | 0.14 (2.29%) |
5.73 - 11.68 | 314,316 | 180,000 | 1,442 | |
| 03-08-2021 | AH | 4:15 PM ET (Aug 3) |
CTSO | Cytosorbents Corporation | 328.43 | -0.11 | -0.03 | -0.08 | Cytosorbents EPS misses by $0.06, beats on revenue [8/3/2021 4:35 PM] |
7.01 | -0.24 (-3.37%) |
7.30 | 0.04 (0.55%) |
7.01 - 11.68 | 211,509 | 150,000 | 388 | |
|
||||||||||||||||||
| 04-05-2021 | AH | 4:15 PM ET (May 4) |
CTSO | Cytosorbents Corporation | 392.74 | -0.10 | -0.03 | -0.10 | Cytosorbents EPS misses by $0.05, misses on revenue [5/4/2021 4:33 PM] |
8.70 | -0.39 (-4.29%) |
8.50 | -0.59 (-6.49%) |
7.13 - 11.74 | 450,129 | 220,000 | 7,639 | |
| 09-03-2021 | AH | 4:15 PM ET (Mar 9) |
CTSO | Cytosorbents Corporation | 370.29 | N/A | -0.04 | -0.13 | Cytosorbents EPS beats by $0.03, beats on revenue [3/9/2021 4:21 PM] |
8.56 | -0.19 (-2.17%) |
9.15 | 0.40 (4.57%) |
3.60 - 11.74 | 306,589 | 296,352 | 259 | |
|
||||||||||||||||||
| 04-11-2020 | AH | 4:15 PM ET (Nov 4) |
CTSO | Cytosorbents Corporation | 346.99 | -0.02 | -0.09 | -0.21 | Cytosorbents EPS beats by $0.07, beats on revenue [11/4/2020 4:23 PM] |
8.92 | 0.53 (6.32%) |
8.90 | 0.51 (6.08%) |
3.49 - 11.74 | 460,890 | 282,170 | 5,325 | |
|
|
||||||||||||||||||
| 04-08-2020 | AH | 4:15 PM ET (Aug 4) |
CTSO | Cytosorbents Corporation | 411.47 | -0.08 | -0.08 | -0.11 | Cytosorbents EPS in-line, misses on revenue [8/4/2020 4:33 PM] |
9.94 | 0.53 (5.63%) |
9.30 | -0.11 (-1.17%) |
3.49 - 11.74 | 425,265 | 1,012,793 | 139 | |
|
|
||||||||||||||||||
| 05-05-2020 | AH | 4:15 PM ET (May 5) |
CTSO | Cytosorbents Corporation | 311.42 | -0.10 | -0.14 | -0.15 | Cytosorbents EPS beats by $0.05, beats on revenue [5/5/2020 4:19 PM] |
9.31 | -0.07 (-0.75%) |
10.10 | 0.79 (8.49%) |
3.49 - 10.24 | 471,069 | 835,146 | 9,333 | |
|
|
||||||||||||||||||